Presentation is loading. Please wait.

Presentation is loading. Please wait.

Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients  Lucy Y. Liu, BA, Brittany.

Published byJosephine Spencer Modified over 6 years ago

Similar presentations

Presentation on theme: "Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients  Lucy Y. Liu, BA, Brittany."— Presentation transcript:

1 Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients  Lucy Y. Liu, BA, Brittany G. Craiglow, MD, Brett A. King, MD, PhD  Journal of the American Academy of Dermatology  Volume 78, Issue 2, Pages e1 (February 2018) DOI: /j.jaad Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Alopecia areata patient 1 before (A) and after 4 months (B) and 6 months (C) of treatment with tofacitinib 2% ointment. Ointment was applied only to the right half of the scalp for the first 2 months, at which time hair regrowth was evident only in the area of drug application. Subsequently, ointment was applied to the entire scalp. At month 4, there was more hair on the right scalp than on the left scalp. By month 6, hair growth was prominent on both sides. Journal of the American Academy of Dermatology  , e1DOI: ( /j.jaad ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Download ppt "Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients  Lucy Y. Liu, BA, Brittany."

Similar presentations

Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)  Jeff Donovan, MD, PhD, FRCPC  JAAD.

Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)  Jeff Donovan, MD, PhD, FRCPC  JAAD.
Molluscum contagiosum infection during the treatment of vitiligo with tacrolimus ointment  Bong Kyun Ahn, MD, Byoung-Dae Kim, MD, Sang Ju Lee, MD, Seung.

Molluscum contagiosum infection during the treatment of vitiligo with tacrolimus ointment  Bong Kyun Ahn, MD, Byoung-Dae Kim, MD, Sang Ju Lee, MD, Seung.
Jeff Donovan, MD, PhD, FRCPC  JAAD Case Reports 

Jeff Donovan, MD, PhD, FRCPC  JAAD Case Reports 
Tsung-Yu Tsai, MD, Yu-Chen Huang, MD 

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD 
Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH 

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH 
Clinical efficacy of diphenylcyclopropenone in alopecia areata: Retrospective data analysis of 50 patients  Katherine Chiang, BSE, Natasha Atanaskova.

Clinical efficacy of diphenylcyclopropenone in alopecia areata: Retrospective data analysis of 50 patients  Katherine Chiang, BSE, Natasha Atanaskova.
Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata  Yong Hyun Jang, MD,

Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata  Yong Hyun Jang, MD,
A girl with a solitary red bulla

A girl with a solitary red bulla
Facial adenocarcinoma treated with intra-arterial chemotherapy

Facial adenocarcinoma treated with intra-arterial chemotherapy
Hydroxychloroquine is ineffective in treatment of alopecia totalis and extensive alopecia areata: A case series of 8 patients  Christoffer V. Nissen,

Hydroxychloroquine is ineffective in treatment of alopecia totalis and extensive alopecia areata: A case series of 8 patients  Christoffer V. Nissen,
Yul W. Yang, MD, PhD, David J. DiCaudo, MD 

Yul W. Yang, MD, PhD, David J. DiCaudo, MD 
Baldness reversed by chemotherapy

Baldness reversed by chemotherapy
Hypertrichosis around a leg ulcer being treated with prostaglandin E1 ointment  Tetsuya Honda, MD, PhD, Satoshi Koreeda, MD, PhD, Yoshiki Miyachi, MD,

Hypertrichosis around a leg ulcer being treated with prostaglandin E1 ointment  Tetsuya Honda, MD, PhD, Satoshi Koreeda, MD, PhD, Yoshiki Miyachi, MD,
Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 
María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD 

María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD 
The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.
Permanent chemotherapy-induced alopecia: A review

Permanent chemotherapy-induced alopecia: A review
JAK inhibitors in dermatology: The promise of a new drug class

JAK inhibitors in dermatology: The promise of a new drug class
Laser-assisted drug delivery: Enhanced response to ingenol mebutate after ablative fractional laser treatment  Stephan Alexander Braun, MD, Peter Hevezi,

Laser-assisted drug delivery: Enhanced response to ingenol mebutate after ablative fractional laser treatment  Stephan Alexander Braun, MD, Peter Hevezi,
Lucy Yichu Liu, Brett Andrew King 

Lucy Yichu Liu, Brett Andrew King 

Similar presentations

Ads by Google